Lu Xie

15PUBLICATIONS
42CO-AUTHORS
Nanotoxicology, health and safetyPredictive and prognostic markersMolecular targetsPharmaceutical delivery technologiesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 19, 2026
Computational prediction of TCR cross-reactivity: principles, challenges and translational opportunities.

|May 04, 2026
Patient-derived organotypic tumor spheroids as a functional platform for predicting immunotherapeutic responses and guiding precision treatment for hepatocellular carcinoma.

|Mar 28, 2026
Single-Cell Multi-Tissue T Cell Clonal Dynamics Reveal Distinct Immune Coercion Landscapes in MSI and MSS Colorectal Cancer.

Qianhe Zhan, Siwen Zhang, Bofu Cao

|Jan 11, 2026
ProTCR: a protein language model-driven framework for decoding TCR-antigen recognition toward precision immunotherapies.

Minrui Xu, Manman Lu, Peng Liu

|Dec 22, 2025
Plasma Proteomics Identifies Thousand-and-One-Amino Acid Kinase 3 as a Potential Biomarker of Rheumatoid Arthritis Activity and a Novel Therapeutic Target.

Pengfei Xin, Wenzhen Li, Xinyu A

|Nov 19, 2025
Targeting the origins of multiple myeloma along hematopoietic stem cell lymphoid lineage differentiation.

Jiaojiao Guo, Yaru Li, Zhiling Yan

Pageof 3

Frequent Collaborators

4 joint publications

Zhenhao Liu

2 joint publications

Hui Cui

2 joint publications

Ying Yu

2 joint publications

Xinrong Yang